TITLE

The use of highly active retroviral therapy to reduce HIV incidence at the population level

AUTHOR(S)
Anema, Aranka; Wood, Evan; Montaner, Julio S. G.
PUB. DATE
July 2008
SOURCE
CMAJ: Canadian Medical Association Journal;7/1/2008, Vol. 179 Issue 1, p13
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author expresses his views on the highly active antiretroviral therapy as a possible drug in reducing human immunodeficiency syndrome (HIV) at population level. The author cites clinical trials showing that antiretroviral therapy has successfully prevents transmission of HIV from mother to child by lowering maternal plasma concentrations. The author also presented a table showing potential challenges and successes of the therapy to all people with HIV indication.
ACCESSION #
32678876

 

Related Articles

  • Antiretroviral Medication and HIV Prevention: New Steps Forward and New Questions. Mayer, Kenneth H.; Krakower, Douglas // Annals of Internal Medicine;2/21/2012, Vol. 156 Issue 4, p312 

    During the past 2 years, several pivotal clinical trials have proven that the use of antiretrovirals by HIV-infected and at-risk uninfected persons can decrease the probability of HIV being transmitted sexually. The initial chemoprophylaxis studies evaluated tenofovir administered topically or...

  • Participants as community-based peer educators: Impact on a clinical trial site in KwaZulu-Natal. Naidoo, Sarita; Morar, Neetha S.; Ramjee, Gita // South African Journal of Science;Jul/Aug2013, Vol. 109 Issue 7/8, p1 

    Participant recruitment, retention and product adherence are necessary to measure the efficacy or effectiveness of an intervention in a clinical trial. As part of a Phase III HIV prevention trial in a rural area in Kwazulu-Natal, South Africa, a peer educator programme was initiated to aid in...

  • HPTN 052 HIV Prevention Trial Named Top 2011 Breakthrough. Breindl, Anette // BioWorld Today;12/27/2011, Vol. 22 Issue 247, p1 

    The article announces that the HPTN 052 study was adjudged as the 2011 Breakthrough of the Year by "Science" magazine and the American Association for the Advancement of Science. The research is stated to be testing the theory that medicine can be used to prevent the spread of a disease....

  • Vaginal gel may help prevent HIV.  // Contemporary Sexuality;Sep2010, Vol. 44 Issue 9, p6 

    This article reports on a study of vaginal gels that contain the antiretroviral drug tenofovir and whether they can help prevent human immunodeficiency virus (HIV).

  • Early drug therapy reduces HIV transmission, study says. Taylor, Billy // Pink Paper;5/20/2011, p1 

    The article provides information on a medical study which evaluated the effectiveness of anti-retroviral therapy in preventing HIV transmission.

  • Daily pill for HIV-negative people can prevent HIV.  // Africa Health;Jul2011, Vol. 33 Issue 5, p10 

    The article reports on findings of the two studies which discover that a daily antiretroviral tablet can prevent heterosexual human immunodeficiency virus (HIV) transmission.

  • Early Use of Antiretrovirals May Reduce HIV Transmission. Norman, Kayda // Applied Clinical Trials;Jun2011, Vol. 20 Issue 6, p17 

    The article discusses the findings of a study on a clinical trial known as the HPTN 052 in relation to the early use of oral antiretroviral therapy (ART). It states that the early use of ART may reduce the likelihood that a person with human immunodeficiency virus (HIV) will pass the virus to...

  • PrEParing the way. Murphy, Dean // HIV Australia;2011, Vol. 9 Issue 3, p9 

    The article presents results of several clinical trials of various antiretroviral (ARV)-based HIV prevention strategies. The HPTN 052 trial showed that initiation of ARV treatment by the partner who is HIV-positive revealed a 96% decrease in HIV transmission. A Phase III clinical trial named...

  • Cash infusion for HIV microbicides. Siva, Nayanah // Nature Biotechnology;May2009, Vol. 27 Issue 5, p401 

    The article discusses a large sum of grants that has been pledged to the International Partnership for Microbicides. The money stems from the Bill and Melinda Gates Foundation, as well as the United Kingdom’s Department for International Development (DFID). These appropriations were...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics